Minimally Invasive Spinal Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Minimally Invasive Spinal Devices Pipeline Market Report Overview

Minimally invasive spine (MIS) fusion surgery is performed to stabilize the vertebral bones and joints using devices such as cannulated and non-cannulated screws. The minimally invasive spinal devices pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Territories ·       The United States

·       China

·       Europe

·       Japan

·       Switzerland

Key Categories ·       Cannulated Screws

·       Rods

·       Interbody Cages

Key Regulatory Paths ·       NMPA

·       PMA

·       510(k)

·       CE

·       de novo

Leading Companies ·       Bonovo Orthopedics Inc

·       CTL Amedica Corp

·       Discure Technologies Ltd

·       Implanet SA

·       Integra LifeSciences Holdings Corp

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Minimally Invasive Spinal Devices Pipeline Market Segmentation by Categories

A few of the key categories in the minimally invasive spinal devices pipeline market are cannulated screws, rods, and interbody cages. As of October 2024, cannulated screws had the highest number of pipeline products.

Minimally Invasive Spinal Devices Pipeline Market Analysis by Categories, 2024 (%)

Minimally Invasive Spinal Devices Pipeline Market Analysis by Categories, 2024 (%)

Buy the Full Report for More Category Insights into the Minimally Invasive Spinal Devices Pipeline Market

Download a Free Report Sample

Minimally Invasive Spinal Devices Pipeline Market Segmentation by Territories

A few of the key territories associated with the minimally invasive spinal devices pipeline market are the United States, China, Europe, Japan, and Switzerland among others. As of October 2024, the US had the highest number of minimally invasive spinal devices pipeline products.

Minimally Invasive Spinal Devices Pipeline Market Analysis by Territories, 2024 (%)

Minimally Invasive Spinal Devices Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Minimally Invasive Spinal Devices Pipeline Market

Download a Free Report Sample

Minimally Invasive Spinal Devices Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths in the minimally invasive spinal devices pipeline products market are NMPA, PMA, 510(k), CE, and de novo among others. As of October 2024, NMPA was the most followed pathway for pipeline products in the minimally invasive spinal devices market.

Minimally Invasive Spinal Devices Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Minimally Invasive Spinal Devices Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Minimally Invasive Spinal Devices Pipeline Market

Download a Free Report Sample

Minimally Invasive Spinal Devices Pipeline Market – Competitive Landscape

A few of the key companies associated with the minimally invasive spinal devices pipeline market are Bonovo Orthopedics Inc, CTL Amedica Corp, Discure Technologies Ltd, Implanet SA, and Integra LifeSciences Holdings Corp among others.

Bonovo Orthopedics Inc: Bonovo Orthopedics Inc (Bonovo) is a medical device company that offers joint care products. The company develops and manufactures orthopedic implants and other orthopedic products to the Chinese healthcare market. The company’s product portfolio includes minimally invasive spine products, cervical spine products, and thoracic and lumbar spine products.

CTL Amedica Corp: CTL Amedica Corp is a medical equipment manufacturing company that focuses on the development and design of multifaceted implants and instruments used in spine injury. The company is headquartered in Addison, Texas, the US.

Minimally Invasive Spinal Devices Pipeline Market Analysis by Companies, As of October 2024
Minimally Invasive Spinal Devices Pipeline Market Analysis by Companies, As of October 2024Buy the Full Report for More Company Insights into the Minimally Invasive Spinal Devices Pipeline Market
Download a Free Report Sample

Segments Covered in the Report

Minimally Invasive Spinal Devices Pipeline Market Territories Outlook (2024)

  • The United States
  • China
  • Europe
  • Japan
  • Switzerland

Minimally Invasive Spinal Devices Pipeline Market Regulatory Paths Outlook (2024)

  • NMPA
  • PMA
  • 510(k)
  • CE
  • de novo

Minimally Invasive Spinal Devices Pipeline Market Categories Outlook (2024)

  • Cannulated Screws
  • Rods
  • Interbody Cages

Scope

This report provides:

  • Extensive coverage of the minimally invasive spinal devices under development.
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details, and other developmental activities.
  • The report reviews the major players involved in the development of minimally invasive spinal devices and lists all their pipeline projects.
  • Overview of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • The report provides key clinical trial data of ongoing trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of minimally invasive spinal devices under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Bonovo Orthopedics Inc
CTL Amedica Corp
Discure Technologies Ltd
Implanet SA
Integra LifeSciences Holdings Corp
MicroPort Scientific Corp
OrthoPediatrics Corp
OxSonics Ltd
Safe SA
SeaSpine, Inc.
Spine Chronicle Japan Co Ltd
SpineGuard SA
SpinePoint LLC
Stryker Corp
SurGenTec LLC
The Chaim Sheba Medical Center
ZuriMED Technologies AG

Table of Contents

  • 1 Table of Contents
  • 1.1 List of Tables
  • 1.2 List of Figures
  • 2 Introduction

    • 2.1 Minimally Invasive Spinal Devices Overview

  • 3 Products under Development

    • 3.1 Minimally Invasive Spinal Devices – Pipeline Products by Stage of Development
    • 3.2 Minimally Invasive Spinal Devices – Pipeline Products by Segment
    • 3.3 Minimally Invasive Spinal Devices – Pipeline Products by Territory
    • 3.4 Minimally Invasive Spinal Devices – Pipeline Products by Regulatory Path
    • 3.5 Minimally Invasive Spinal Devices – Pipeline Products by Estimated Approval Date
    • 3.6 Minimally Invasive Spinal Devices – Ongoing Clinical Trials

  • 4 Minimally Invasive Spinal Devices – Pipeline Products under Development by Companies

    • 4.1 Minimally Invasive Spinal Devices Companies – Pipeline Products by Stage of Development
    • 4.2 Minimally Invasive Spinal Devices – Pipeline Products by Stage of Development

  • 5 Minimally Invasive Spinal Devices Companies and Product Overview

    • 5.1 Bonovo Orthopedics Inc Company Overview

      • 5.1.1 Bonovo Orthopedics Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.2 CTL Amedica Corp Company Overview

      • 5.2.1 CTL Amedica Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.3 Discure Technologies Ltd Company Overview

      • 5.3.1 Discure Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.4 Implanet SA Company Overview

      • 5.4.1 Implanet SA Pipeline Products & Ongoing Clinical Trials Overview

    • 5.5 Integra LifeSciences Holdings Corp Company Overview

      • 5.5.1 Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.6 MicroPort Scientific Corp Company Overview

      • 5.6.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.7 OrthoPediatrics Corp Company Overview

      • 5.7.1 OrthoPediatrics Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.8 OxSonics Ltd Company Overview

      • 5.8.1 OxSonics Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.9 Safe SA Company Overview

      • 5.9.1 Safe SA Pipeline Products & Ongoing Clinical Trials Overview

    • 5.10 SeaSpine, Inc. Company Overview

      • 5.10.1 SeaSpine, Inc. Pipeline Products & Ongoing Clinical Trials Overview

    • 5.11 Spine Chronicle Japan Co Ltd Company Overview

      • 5.11.1 Spine Chronicle Japan Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.12 SpineGuard SA Company Overview

      • 5.12.1 SpineGuard SA Pipeline Products & Ongoing Clinical Trials Overview

    • 5.13 SpinePoint LLC Company Overview

      • 5.13.1 SpinePoint LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.14 Stryker Corp Company Overview

      • 5.14.1 Stryker Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.15 SurGenTec LLC Company Overview

      • 5.15.1 SurGenTec LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.16 The Chaim Sheba Medical Center Company Overview

      • 5.16.1 The Chaim Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview

    • 5.17 ZuriMED Technologies AG Company Overview

      • 5.17.1 ZuriMED Technologies AG Pipeline Products & Ongoing Clinical Trials Overview

  • 6 Minimally Invasive Spinal Devices- Recent Developments

    • 6.1 Oct 08, 2024: SpineGuard Receives 510(K) Clearance For Cannulated PsiFGuard
    • 6.2 Sep 30, 2024: SpineGuard Obtains FDA Clearance for Commercial Release of Its “PsiFGuard” New Smart Drilling Device Dedicated to Sacroiliac Joint Fusion
    • 6.3 Jul 10, 2024: Aurora Spine Corporation to Attend Sixth Annual American Society of Pain & Neuroscience Conference
    • 6.4 Jul 04, 2024: SurGenTec Receives An Additional 510(K) Clearance For Ion Facet Screw System
    • 6.5 May 30, 2024: Partnership With Key Opinion Leaders and Successful Trainings
    • 6.6 Mar 12, 2024: Modified MAGEC X System for Early Onset Scoliosis Treatment Can Now be used in the UK
    • 6.7 Feb 15, 2024: SurGenTec Receives Additional 510(K) Clearance For Ion Facet Screw System
    • 6.8 Dec 12, 2023: ZimVie Announces Compatibility Between its Vital Spinal Fixation System and Brainlab Spine & Trauma Navigation
    • 6.9 Nov 13, 2023: Aurora Spine Schedules Conference Call to Update Investors and Discuss Third Quarter Fiscal Year 2023 Financial Results

  • 7 Appendix

    • 7.1 Methodology
    • 7.2 About GlobalData
    • 7.3 Contact Us
    • 7.4 Disclaimer

Table

Minimally Invasive Spinal Devices – Pipeline Products by Stage of Development

Minimally Invasive Spinal Devices – Pipeline Products by Segment

Minimally Invasive Spinal Devices – Pipeline Products by Territory

Minimally Invasive Spinal Devices – Pipeline Products by Regulatory Path

Minimally Invasive Spinal Devices – Pipeline Products by Estimated Approval Date

Minimally Invasive Spinal Devices – Ongoing Clinical Trials

Minimally Invasive Spinal Devices Companies – Pipeline Products by Stage of Development

Minimally Invasive Spinal Devices – Pipeline Products by Stage of Development

Bonovo Orthopedics Inc Pipeline Products & Ongoing Clinical Trials Overview

Pioneer QUANTUM Spinal Rodding System – Product Status

Pioneer QUANTUM Spinal Rodding System – Product Description

CTL Amedica Corp Pipeline Products & Ongoing Clinical Trials Overview

Minimally Invasive Flex Tower – Product Status

Minimally Invasive Flex Tower – Product Description

Discure Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview

Discure System – Product Status

Discure System – Product Description

Discure Technologies Ltd – Ongoing Clinical Trials Overview

Discure System – A Prospective Study to Assess the Safety and Performance of the Discure Technologies System for the Treatment of Early to Moderate Degenerative Disc Disease (DDD)

Implanet SA Pipeline Products & Ongoing Clinical Trials Overview

Jazz Claw Connector – Product Status

Jazz Claw Connector – Product Description

Jazz Claw System – Product Status

Jazz Claw System – Product Description

JAZZ Frame System – Product Status

JAZZ Frame System – Product Description

Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview

ESS+ Rod – Product Status

ESS+ Rod – Product Description

MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview

Cannulated Screw – Product Status

Cannulated Screw – Product Description

OrthoPediatrics Corp Pipeline Products & Ongoing Clinical Trials Overview

Growing Rod – Product Status

Growing Rod – Product Description

OxSonics Ltd Pipeline Products & Ongoing Clinical Trials Overview

UltraSpine – Product Status

UltraSpine – Product Description

Safe SA Pipeline Products & Ongoing Clinical Trials Overview

Oak screw – Cemetable Version – Product Status

Oak screw – Cemetable Version – Product Description

SeaSpine, Inc. Pipeline Products & Ongoing Clinical Trials Overview

PROW – Degenerative Disc Disease – Product Status

PROW – Degenerative Disc Disease – Product Description

PROW – Herniated Disc – Product Status

PROW – Herniated Disc – Product Description

PROW – Spinal Tumor – Product Status

PROW – Spinal Tumor – Product Description

PROW – Spondylolisthesis – Product Status

PROW – Spondylolisthesis – Product Description

PROW Implant – Trauma – Product Status

PROW Implant – Trauma – Product Description

Spine Chronicle Japan Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Spacro Screw-Anchored Kyphoplasty Device – Product Status

Spacro Screw-Anchored Kyphoplasty Device – Product Description

SpineGuard SA Pipeline Products & Ongoing Clinical Trials Overview

Cannulated PsiFGuard – Product Status

Cannulated PsiFGuard – Product Description

SpinePoint LLC Pipeline Products & Ongoing Clinical Trials Overview

Cervical Cage – Product Status

Cervical Cage – Product Description

Stryker Corp Pipeline Products & Ongoing Clinical Trials Overview

Xia Cannulated Polyaxial Screw – Product Status

Xia Cannulated Polyaxial Screw – Product Description

SurGenTec LLC Pipeline Products & Ongoing Clinical Trials Overview

Ion Facet Screw System – Product Status

Ion Facet Screw System – Product Description

The Chaim Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview

Transarticular Cannulated Fenestrated Screw – Product Status

Transarticular Cannulated Fenestrated Screw – Product Description

ZuriMED Technologies AG Pipeline Products & Ongoing Clinical Trials Overview

Surgical-Fiberlock – Herniated Lumbar Disc – Product Status

Surgical-Fiberlock – Herniated Lumbar Disc – Product Description

Glossary

Figures

Minimally Invasive Spinal Devices – Pipeline Products by Stage of Development

Minimally Invasive Spinal Devices – Pipeline Products by Segment

Minimally Invasive Spinal Devices – Pipeline Products by Territory

Minimally Invasive Spinal Devices – Pipeline Products by Regulatory Path

Minimally Invasive Spinal Devices – Pipeline Products by Estimated Approval Date

Minimally Invasive Spinal Devices – Ongoing Clinical Trials

Frequently asked questions

Minimally Invasive Spinal Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$2,500

Can be used by individual purchaser only

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Minimally Invasive Spinal Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Minimally Invasive Spinal Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Minimally Invasive Spinal Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.